Sykes And Ray Equities Open An Account Button
SRE India Mobile Trading App Download Promotion
Sykes And Ray Equities India Start SIP Investment Visual
Sykes And Ray Equities India Start Trading Online Visual

Markets

Market Nav

News Details

19/05/2026 14:30

Zydus Lifesciences Q4 net profit down 38.80% at Rs 1722.00 cr

The company reported standalone net profit of Rs 1,722.00 crore for the quarter ended March 31, 2026 as compared to Rs 2813.70 crore in the same period last year, registering a year-on-year decline of 38.80 per cent.

Net revenue of the company declined substantially by 36.72 per cent at Rs 3,564.60 crore in January-March quarter of this fiscal as against Rs 5,633.50 crore in the corresponding period last year.

During January-March quarter, operating expenses dropped by 14.42 per cent to Rs 1,751.80 crore from Rs 2,046.90 crore in year ago period.

Other Income grew by 167.04 per cent at Rs 495.10 crore versus (Mar'25 Rs 185.40 crore).

Operating Profit slipped by 47.28 per cent to Rs 1,989.10 crore as against Rs 3,772.70 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 16.68 per cent in March quarter.

Interest declined by 25.68 per cent y-o-y to Rs 115.50 crore, while Taxation decreased by 54.82 per cent at Rs 389.00 crore (Mar'25 Rs 861.00 crore).